“Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide and/or lorcaserin treatment in humans with obesity and/or diabetes”

Presented at : GDF-15 Scientific Poster Presented at the recent 20th World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease

This study was investigator initiated and funded.

NOTICE: Unless otherwise stated in our catalog or other product documentation, information presented in our scientific poster sessions is to be considered as Research Use Only.